lecture at the weekly meeting of the staff of the 1\layo Clinic on the use of vitamin K to correct deficiency of prothrombin associated with jaundice and disease of the liver. In the course of that lecture he mentioned a com-I)ound that had been prepared which was capable of producing a deficiency of prothrombin in animals. This state apparently could not be corrected by the administration of vitamin K. After the lecture I asked Dr. Butt about the new preparation, and found that he had read about it only a feew days previously in the Joarnial of Biological Chemistry. The work had been done by Dr. Karl P. Link and his associates at the University of Wisconsin. Dr thrombosis and embolism, but it had disadvantages, specifically-ill its short action, its need for parenteral administration, and its considerable cost. I had believed for some time that another Preparation could be used that would abolish these objections and that would be beneficial in the care of patients with vascular thrombosis and embolism.
On May 9, 1941, Dr. Butt and I administered Dicumarol to all organiically sound young man who was 19 years old and who weighed 80 Kg. We had no alternative but to guess at the proper dose; we gave too mnuch, that is, 1.8 Gm. in 5 days. Onl the sixth day after our patient first swallowed the Dieumarol, Miss Margaret M. Hurn, wcho was determiningy prothrombin activity in the blood, called ne, with some concern, to say that our patient had almost no prothrombin in his blood ( fig.  1 ). Moreover, the coagulation time of the blood was prolonged ( fig. 2 ): Dr. Butt and I shared Miss llurm's concern, for we were conscious of the possibility of severe hemorrhage.
Although at that time vitamin K was considered to lack the ability to increase prothrombin activity whenl deficiency of prothrombin was induced by Dicumuarol, ve grave the patient 20 mug. of synthetic vitamin K illtravenously, at the suggestion of Dr. Butt. The prothrombin time decreased from 140 to 87 seconds within 24 hours, but at the end of another 24 hour period the prothroiiibiii time was 161 seconds. It was only many months later, when reviewing the clinical record of the patient, that we recognized that there had been substantial increase inl prothrombiin activity attributable to the use of vitamin IK. Until that time we had believed that the recorded change ill prothronibin activity had been a " normal fluctuation. " When we finally recognize(d, in retrospect, the specific effect of vitamiini K onl the blood of our patiemit, it had already been demonstrated that large doses of Circulation, Volume XIX, January, 19.9 lw %.. practice; the use of them has saved manylives. The story which I have related, based on my personal participation in it, is the story, " From the Haystack to the Human,'* for treatment of diseases of man with Dieuimiarol resulted from original studies by Link amid his associates oim the cause of hemorrhagic disease of cattle which occurred when they ate spoiled sweet-clover lhay.
There is another chapter yet to be written.
Idenitical amounts of Dicumnarol and substaimces that have a similar action produce diverse effects omi the prothromnbiim activity of differemit lversons, anid omi the prothrombin activity of the same person at different times. hence, an effect that is constant in quality cannot be anticipated accurately. What is llrgently needed is a l)reparation which, when administered in the same amount, always produces the same effect. Such ail accomplishmnent seemls improbable amid perhaps impossible, but we are bouiid to remember that in 1939 Dicumarol also wras 'imnpossible." *The designation of a newspaper reporter.
